Description
DAPAFLO 5MG is a medication containing Dapagliflozin 5 mg, a pharmaceutical agent belonging to the class of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors. This innovative drug primarily functions by promoting the excretion of glucose from the body via urine, thereby effectively lowering blood sugar levels. Beyond its glucose-lowering effects, Dapagliflozin also aids in reducing fluid and sodium retention, contributing to significant benefits for cardiovascular and renal health.
DAPAFLO 5MG is widely prescribed for the management of Type 2 Diabetes Mellitus, improving glycemic control in adults and adolescents aged 10 years and older. While the 10mg strength is more commonly used for heart failure and chronic kidney disease, the 5mg dose may be prescribed for specific patient needs or as a starting dose for these conditions. As a prescription-only medication, it is typically taken once daily. Key side effects include an increased risk of genitourinary infections and the rare but serious possibility of diabetic ketoacidosis.
